BACKGROUND AND AIM: The definition as well as the treatment of women with mixed urinary incontinence (MUI) is controversial. Since women with MUI are a heterogeneous group, the treatment of MUI requires an individual assessment of the symptom components: stress urinary incontinence, urinary urgency, urgency urinary incontinence, urinary frequency, and nocturia. The purpose of this paper is to summarize the current literature and give an evidence-based review of the assessment and treatment of MUI. METHODS: A working subcommittee from the International Urogynecological Association (IUGA) Research and Development (R&D) Committee was formed. An initial document addressing the diagnosis and management of MUI was drafted based on a literature review. After evaluation by the entire IUGA R&D Committee, revisions were made, and the final document represents the IUGA R&D Committee Opinion on MUI. RESULTS: This R&D Committee Opinion reviews the literature on MUI and summarizes the assessment and treatment with evidence-based recommendations. CONCLUSIONS: The diagnosis of MUI encompasses a very heterogeneous group of women. The evaluation and treatment requires an individualized approach. The use of validated questionnaires is recommended to assess urinary incontinence symptoms and effect on quality of life. Conservative therapy is suggested as a first-line approach; if surgery is contemplated, urodynamic investigation is recommended. Women undergoing surgical treatment for MUI need to be counselled about the possibility of persistence of urinary urgency, frequency and urge incontinence even if stress urinary incontinence is cured.
BACKGROUND AND AIM: The definition as well as the treatment of women with mixed urinary incontinence (MUI) is controversial. Since women with MUI are a heterogeneous group, the treatment of MUI requires an individual assessment of the symptom components: stress urinary incontinence, urinary urgency, urgency urinary incontinence, urinary frequency, and nocturia. The purpose of this paper is to summarize the current literature and give an evidence-based review of the assessment and treatment of MUI. METHODS: A working subcommittee from the International Urogynecological Association (IUGA) Research and Development (R&D) Committee was formed. An initial document addressing the diagnosis and management of MUI was drafted based on a literature review. After evaluation by the entire IUGA R&D Committee, revisions were made, and the final document represents the IUGA R&D Committee Opinion on MUI. RESULTS: This R&D Committee Opinion reviews the literature on MUI and summarizes the assessment and treatment with evidence-based recommendations. CONCLUSIONS: The diagnosis of MUI encompasses a very heterogeneous group of women. The evaluation and treatment requires an individualized approach. The use of validated questionnaires is recommended to assess urinary incontinence symptoms and effect on quality of life. Conservative therapy is suggested as a first-line approach; if surgery is contemplated, urodynamic investigation is recommended. Women undergoing surgical treatment for MUI need to be counselled about the possibility of persistence of urinary urgency, frequency and urge incontinence even if stress urinary incontinence is cured.
Authors: Linda Brubaker; Emily S Lukacz; Kathryn Burgio; Philippe Zimmern; Peggy Norton; Wendy Leng; Harry Johnson; Stephen Kraus; Anne Stoddard Journal: Neurourol Urodyn Date: 2011-01 Impact factor: 2.696
Authors: Catherine S Bradley; Eric S Rovner; Mark A Morgan; Michelle Berlin; Joseph M Novi; Judy A Shea; Lily A Arya Journal: Am J Obstet Gynecol Date: 2005-01 Impact factor: 8.661
Authors: Linda Brubaker; Anne Stoddard; Holly Richter; Philippe Zimmern; Pamela Moalli; Stephen R Kraus; Peggy Norton; Emily Lukacz; Larry Sirls; Harry Johnson Journal: Neurourol Urodyn Date: 2009 Impact factor: 2.696
Authors: Jean E Kincade; Molly C Dougherty; John R Carlson; Georgia S Hunter; Jan Busby-Whitehead Journal: Neurourol Urodyn Date: 2007 Impact factor: 2.696
Authors: Stefan Mohr; Christine Marthaler; Sara Imboden; Ash Monga; Michel D Mueller; Annette Kuhn Journal: Int Urogynecol J Date: 2017-04-17 Impact factor: 2.894
Authors: Vivian W Sung; Diane Borello-France; Gena Dunivan; Marie Gantz; Emily S Lukacz; Pamela Moalli; Diane K Newman; Holly E Richter; Beri Ridgeway; Ariana L Smith; Alison C Weidner; Susan Meikle Journal: Int Urogynecol J Date: 2016-06-10 Impact factor: 2.894
Authors: Vivian W Sung; Diane Borello-France; Diane K Newman; Holly E Richter; Emily S Lukacz; Pamela Moalli; Alison C Weidner; Ariana L Smith; Gena Dunivan; Beri Ridgeway; John N Nguyen; Donna Mazloomdoost; Benjamin Carper; Marie G Gantz Journal: JAMA Date: 2019-09-17 Impact factor: 56.272
Authors: Vivian W Sung; Holly E Richter; Pamela Moalli; Alison C Weidner; John N Nguyen; Ariana L Smith; Gena Dunivan; Beri Ridgeway; Diane Borello-France; Diane K Newman; Donna Mazloomdoost; Benjamin Carper; Marie G Gantz Journal: Obstet Gynecol Date: 2020-09 Impact factor: 7.623